Terms: = Breast cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
295 results:
1. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1.
Zhao Y; Liu Z; Liu G; Zhang Y; Liu S; Gan D; Chang W; Peng X; Sung ES; Gilbert K; Zhu Y; Wang X; Zeng Z; Baldwin H; Ren G; Weaver J; Huron A; Mayberry T; Wang Q; Wang Y; Diaz-Rubio ME; Su X; Stack MS; Zhang S; Lu X; Sheldon RD; Li J; Zhang C; Wan J; Lu X
Cell Metab; 2023 Oct; 35(10):1688-1703.e10. PubMed ID: 37793345
[TBL] [Abstract] [Full Text] [Related]
2. Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
Zhang X; Guo H; Chen J; Xu C; Wang L; Ke Y; Gao Y; Zhang B; Zhu J
Cancer Lett; 2023 Sep; 572():216355. PubMed ID: 37597651
[TBL] [Abstract] [Full Text] [Related]
3. Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer.
Wang Y; Xu M; Sun J; Li X; Shi H; Wang X; Liu B; Zhang T; Jiang X; Lin L; Li Q; Huang Y; Liang Y; Hu M; Zheng F; Zhang F; Sun J; Shi Y; Wang Y
Nat Metab; 2023 Aug; 5(8):1408-1422. PubMed ID: 37563468
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic role of stat5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
5. stat5 inhibits NLRP3-mediated pyroptosis to enhance chemoresistance of breast cancer cells via promoting miR-182 transcription.
Wan P; He X; Han Y; Wang L; Yuan Z
Chem Biol Drug Des; 2023 Jul; 102(1):14-25. PubMed ID: 36905318
[TBL] [Abstract] [Full Text] [Related]
6. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers.
Hathaway CA; Rice MS; Collins LC; Chen D; Frank DA; Walker S; Clevenger CV; Tamimi RM; Tworoger SS; Hankinson SE
Breast Cancer Res; 2023 Mar; 25(1):24. PubMed ID: 36882838
[TBL] [Abstract] [Full Text] [Related]
7. Identification of stat5b as a biomarker associated with prognosis and immune infiltration in breast cancer.
Li J; Li L; Mahesutihan G; Meng J; Chen Y; Lv J
Medicine (Baltimore); 2023 Mar; 102(9):e32972. PubMed ID: 36862902
[TBL] [Abstract] [Full Text] [Related]
8. Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data.
Jia G; Yang Y; Ping J; Xu S; Liu L; Guo X; Tao R; Long J; Zheng W
Int J Cancer; 2023 Jun; 152(11):2314-2320. PubMed ID: 36779764
[TBL] [Abstract] [Full Text] [Related]
9. Immunomodulatory Role of Diospyros peregrina Fruit Preparation in breast cancer by Utilizing Macrophage Mediated Antigen Presentation and T Helper Cell (Th) Differentiation.
Mahalakshmi Surendran A; Rai A; Rakshit S; George M; Sarkar K
Clin Breast Cancer; 2023 Apr; 23(3):e95-e102. PubMed ID: 36641322
[TBL] [Abstract] [Full Text] [Related]
10. Identification of prolactin receptor variants with diverse effects on receptor signalling.
Gorvin CM; Newey PJ; Thakker RV
J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36445946
[TBL] [Abstract] [Full Text] [Related]
11. Combined treatment with ruxolitinib and MK-2206 inhibits the JAK2/stat5 and PI3K/AKT pathways via apoptosis in MDA-MB-231 breast cancer cell line.
Guvenir Celik E; Eroglu O
Mol Biol Rep; 2023 Jan; 50(1):319-329. PubMed ID: 36331743
[TBL] [Abstract] [Full Text] [Related]
12. stat5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential.
Lin M; Ku AT; Dong J; Yue F; Jiang W; Ibrahim AA; Peng F; Creighton CJ; Nagi C; Gutierrez C; Rosen JM; Zhang XH; Hilsenbeck SG; Chen X; Du YN; Huang S; Shi A; Fan Z; Li Y
Oncogene; 2022 Nov; 41(48):5214-5222. PubMed ID: 36261627
[TBL] [Abstract] [Full Text] [Related]
13. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
Kavarthapu R; Dufau ML
Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
[TBL] [Abstract] [Full Text] [Related]
14. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
Wong GL; Manore SG; Doheny DL; Lo HW
Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
[TBL] [Abstract] [Full Text] [Related]
15. Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis.
van der Velden LM; Maas P; van Amersfoort M; Timmermans-Sprang EPM; Mensinga A; van der Vaart E; Malergue F; Viëtor H; Derksen PWB; Klumperman J; van Agthoven A; Egan DA; Mol JA; Strous GJ
Front Endocrinol (Lausanne); 2022; 13():926210. PubMed ID: 35966052
[TBL] [Abstract] [Full Text] [Related]
16. Investigating the molecular mechanisms of Tamoxifen on the EMT pathway among patients with breast cancer.
Mirzaei M; Sheikholeslami SA; Jalili A; Bereimipour A; Sharbati S; Kaveh V; Salari S
J Med Life; 2022 Jun; 15(6):835-844. PubMed ID: 35928368
[TBL] [Abstract] [Full Text] [Related]
17. breast cancer and Prolactin - New Mechanisms and Models.
Clevenger CV; Rui H
Endocrinology; 2022 Oct; 163(10):. PubMed ID: 35922139
[TBL] [Abstract] [Full Text] [Related]
18. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
[TBL] [Abstract] [Full Text] [Related]
19. Caveolae Microdomains Mediate stat5 Signaling Induced by Insulin in MCF-7 breast cancer Cells.
Castillo-Sanchez R; Cortes-Reynosa P; Lopez-Perez M; Garcia-Hernandez A; Salazar EP
J Membr Biol; 2023 Feb; 256(1):79-90. PubMed ID: 35751654
[TBL] [Abstract] [Full Text] [Related]
20. PTHrP induces stat5 activation, secretory differentiation and accelerates mammary tumor development.
Grinman DY; Boras-Granic K; Takyar FM; Dann P; Hens JR; Marmol C; Lee J; Choi J; Chodosh LA; Sola MEG; Wysolmerski JJ
Breast Cancer Res; 2022 Apr; 24(1):30. PubMed ID: 35440032
[TBL] [Abstract] [Full Text] [Related]
[Next]
